Induction of ErbB-3 expression by alpha6beta4 integrin contributes to tamoxifen resistance in ERbeta1-negative breast carcinomas.

In this study, we evaluated the antitumor and antiangiogenic effects on MDA-MB-231 human breast cancer cells and endothelial cells induced by Bothropoidin, a

The compounds were evaluated for their in vitro cytotoxicity activities against cultured human cancer cells of PC-3 human prostate cancer, MCF-7 and MDA-MB-231 breast carcinoma,

mesylates expressed strong antiproliferative activity against steroid receptor-independent tumor cell lines: breast adenocarcinoma (MDA-MB-231), prostate cancer (PC-3) and

Thus, as a first step in assessing their pharmacological properties, the new ruthenium complexes were assayed against human breast tumor cell lines MDA-MB-231 and L929 (ATCC:CCL 1,

Antitumor activity assays of the new complexes using the invasive MDA-MB-231 and non-invasive MCF-7 human breast tumor cell lines indicated a good degree of cytotoxicity for

We compared the proliferation of the human breast cancer cell line MDA-MB-231 and of the non-cancer human mammary epithelial cell line MCF-10A in different experimental

In RNAi- mediated ADAM9 silenced MDA-MB-231 cells, the expression of ADAM9 was lower from the third to the sixth day after silencing and inhibited tumor cell invasion in matrigel

In RNAi- mediated ADAM9 silenced MDA-MB-231 cells, the expression of ADAM9 was lower from the third to the sixth day after silencing and inhibited tumor cell invasion in matrigel